Milestone Pharmaceuticals Inc (NASDAQ: MIST) kicked off on Tuesday, down -6.18% from the previous trading day, before settling in for the closing price of $2.35. Over the past 52 weeks, MIST has traded in a range of $0.63-$3.06.
During the last 5-year period, the sales growth of Healthcare Sector giant was 28.21%. While this was happening, its average annual earnings per share was recorded -6.87%. With a float of $81.04 million, this company’s outstanding shares have now reached $85.17 million.
Milestone Pharmaceuticals Inc (MIST) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Milestone Pharmaceuticals Inc is 4.88%, while institutional ownership is 40.88%.
Milestone Pharmaceuticals Inc (MIST) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.19 earnings per share (EPS), lower than consensus estimate (set at -0.15) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.42% during the next five years compared to 28.21% growth over the previous five years of trading.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Trading Performance Indicators
Take a look at Milestone Pharmaceuticals Inc’s (MIST) current performance indicators. Last quarter, stock had a quick ratio of 8.24. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Milestone Pharmaceuticals Inc (MIST)
Looking closely at Milestone Pharmaceuticals Inc (NASDAQ: MIST), its last 5-days average volume was 24.98 million, which is a jump from its year-to-date volume of 2.28 million. As of the previous 9 days, the stock’s Stochastic %D was 48.85%.
During the past 100 days, Milestone Pharmaceuticals Inc’s (MIST) raw stochastic average was set at 48.19%, which indicates a significant increase from 40.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.18, while its 200-day Moving Average is $1.75. However, in the short run, Milestone Pharmaceuticals Inc’s stock first resistance to watch stands at $2.45. Second resistance stands at $2.69. The third major resistance level sits at $2.82. If the price goes on to break the first support level at $2.08, it is likely to go to the next support level at $1.95. Now, if the price goes above the second support level, the third support stands at $1.71.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Key Stats
The company with the Market Capitalisation of 187.37 million has total of 85,169K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -41,520 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -11,920 K.
